SCHEMBL24722909

SCHEMBL24722909

Cc1ccc2c(c1)COCC1CN(C)CCN21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.36
SLC6A2 P23975 4/20 0.35
SLC6A4 P31645 4/20 0.35
HTR2A P28223 3/20 0.35
KMT2A Q03164 3/20 0.35
LMNA P02545 2/20 0.35
HTR2C P28335 2/20 0.35
HTR2B P41595 2/20 0.35
MEN1 O00255 2/20 0.35
TP53 P04637 2/20 0.35
CYP3A4 P08684 2/20 0.35
KDM4E B2RXH2 2/20 0.35
USP2 O75604 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
TSHR P16473 1/20 0.35
CYP2C19 P33261 1/20 0.35
HTR3E A5X5Y0 1/20 0.35
HTR3B O95264 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL693038 0.85 POLB (0.40) DRD2SLC6A2SLC6A4HTR2AKMT2A
SCHEMBL2018650 0.85 KDM4E (0.46) DRD2SLC6A2SLC6A4HTR2AKMT2A
SCHEMBL691897 0.82 HTR2A (0.49) DRD2SLC6A2SLC6A4HTR2AKMT2A
SCHEMBL693333 0.80 HTT (0.43) KMT2ALMNAMEN1CYP3A4KDM4E
SCHEMBL24722746 0.78 NPSR1 (0.33) HTR2AHTR2CHTR2B
SCHEMBL24722876 0.78 NPSR1 (0.33) HTR2AHTR2CHTR2B
SCHEMBL24722793 0.77 HTR2C (0.50) HTR2AHTR2CHTR2BHTR6
SCHEMBL11830107 0.73 DRD2 (0.41) DRD2SLC6A2SLC6A4HTR2AHTR2C
SCHEMBL24723423 0.71 KDM4E (0.32) HTR2AKMT2AHTR2CHTR2BKDM4E
SCHEMBL24722751 0.71 HRH3 (0.35) HTR2AHTR2CHTR2BADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022166920-A1 PYRROLOPYRIDAZINE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF 杭州中美华东制药有限公司 2022-08-11 WO disclosed